Katie Thomas
Why Are Drug Prices So High? We’re Curious, Too.
The New York Times and ProPublica have teamed up to investigate who is to blame for skyrocketing drug prices — and have turned up some surprising answers.
Generic Drug Prices Are Declining, But Many Consumers Aren’t Benefiting
Outcry has been building over the rising cost of brand-name medications, but the price of generic drugs has been moving in the opposite direction. The stock prices of generic manufacturers have tumbled, but many consumers aren’t paying less at the pharmacy counter.
Take the Generic Drug, Patients Are Told — Unless Insurers Say No
Faced with competition, some pharmaceutical companies are cutting deals with insurance companies to favor their brand-name products over cheaper generics. Insurers pay less, but sometimes consumers pay more.
Drugmakers’ Money-Back Guarantees: an Answer to Rising Prices or a ‘Carnival Game’
Pharmaceutical companies are increasingly agreeing to refund money if patients don't respond to medications as expected. The Trump administration is intrigued, but critics say the deals are unlikely to reduce consumers’ bills.
A Drug Quintupled in Price. Now, Drug Industry Players Are Feuding Over the Windfall.
Amid public concern over spiking drug prices, a powerful middleman is suing a tiny drugmaker over unpaid rebates and fees. The maker calls the suit baseless; analysts say the suit offers a window into an opaque world.
